AUNG, T. H. Proximicin A-C as prospective HER2-positive and negative breast cancer drugs: Molecular docking and in silico ADME modeling. IPS Journal of Molecular Docking Simulations, [S. l.], v. 1, n. 1, p. 1–11, 2022. DOI: 10.54117/ijmds.v1i1.9. Disponível em: https://drugdiscoveryupdate.com/index.php/IJMDS/article/view/9. Acesso em: 6 jul. 2024.